HomeNewsBusinessCompaniesNo product launches by FMCG firms during this Onam in Kerala, but COVID-19 messages in brand promotion stand out

No product launches by FMCG firms during this Onam in Kerala, but COVID-19 messages in brand promotion stand out

Nestle Milkmaid, Marico and Yardley lead the show. Traditionally, the 10-day harvest festival is a broad indicator of consumer sentiment and overall adspend. Owing to COVID-19, campaigns muted this time. Hindustan Unilever has stayed away from big ad spends so far

August 28, 2020 / 12:17 IST
Story continues below Advertisement

Though fast-moving consumer goods (FMCG) companies are not launching products this Onam in Kerala, a few companies have come up with creative campaigns for brand promotions.

Nestle Milkmaid, Marico Parachute Advansed Gold, and Yardley are participating in the festivities spreading the message of care during COVID-19.

Story continues below Advertisement

Onam, a 10-day harvest festival celebrated in Kerala, marks the beginning of the festive season in the country. It started on August 22.

Companies, traditionally, release major ad campaigns during this time, and the festival is a broad indicator of consumer sentiment, overall adspend and their impact on the larger economy.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show